
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
---|---|---|---|---|---|
BLBD
Blue Bird
|
$377.6M | $0.98 | 13.28% | 21.73% | $51.57 |
DCO
Ducommun
|
$199.3M | $0.84 | 1.02% | 55.8% | $94.80 |
FLS
Flowserve
|
$1.2B | $0.78 | 5.58% | 41.72% | $64.30 |
OSK
Oshkosh
|
$2.7B | $2.94 | -6.38% | 15.01% | $126.62 |
PCAR
PACCAR
|
$7B | $1.28 | -12.84% | -22.77% | $102.45 |
XOS
Xos
|
$13.1M | -$1.07 | -15.75% | -13.01% | $6.00 |
Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
---|---|---|---|---|---|---|---|
BLBD
Blue Bird
|
$42.82 | $51.57 | $1.4B | 13.26x | $0.00 | 0% | 1.05x |
DCO
Ducommun
|
$86.50 | $94.80 | $1.3B | 37.12x | $0.00 | 0% | 1.65x |
FLS
Flowserve
|
$53.79 | $64.30 | $7B | 25.14x | $0.21 | 1.56% | 1.54x |
OSK
Oshkosh
|
$123.14 | $126.62 | $7.9B | 13.16x | $0.51 | 1.58% | 0.77x |
PCAR
PACCAR
|
$95.39 | $102.45 | $50.1B | 14.45x | $0.33 | 1.32% | 1.55x |
XOS
Xos
|
$3.34 | $6.00 | $27.8M | -- | $0.00 | 0% | 0.55x |
Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
---|---|---|---|---|
BLBD
Blue Bird
|
32.74% | 1.068 | 9.04% | 0.65x |
DCO
Ducommun
|
25.92% | 2.453 | 28.1% | 2.08x |
FLS
Flowserve
|
41.83% | 2.101 | 23.16% | 1.37x |
OSK
Oshkosh
|
25.87% | 2.785 | 24.36% | 0.82x |
PCAR
PACCAR
|
46.49% | 1.405 | 30.63% | 2.53x |
XOS
Xos
|
45.9% | -0.105 | 86.3% | 0.65x |
Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
---|---|---|---|---|---|---|
BLBD
Blue Bird
|
$70.9M | $33.7M | 43.34% | 69.97% | 9.87% | $18.7M |
DCO
Ducommun
|
$51.6M | $17M | 3.81% | 5.26% | 8.54% | -$4M |
FLS
Flowserve
|
$369.3M | $126.2M | 8.29% | 13.71% | 10.17% | -$61.7M |
OSK
Oshkosh
|
$399.9M | $175.4M | 11.34% | 15.17% | 7.69% | -$435.2M |
PCAR
PACCAR
|
$1.3B | $885.1M | 10.57% | 19.56% | 11.89% | $584.5M |
XOS
Xos
|
$1.2M | -$9.3M | -71.4% | -104.41% | -157.66% | -$4.8M |
Ducommun has a net margin of 7.26% compared to Blue Bird's net margin of 5.42%. Blue Bird's return on equity of 69.97% beat Ducommun's return on equity of 5.26%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
BLBD
Blue Bird
|
19.75% | $0.79 | $283.1M |
DCO
Ducommun
|
26.58% | $0.69 | $935.4M |
Blue Bird has a consensus price target of $51.57, signalling upside risk potential of 20.44%. On the other hand Ducommun has an analysts' consensus of $94.80 which suggests that it could grow by 9.6%. Given that Blue Bird has higher upside potential than Ducommun, analysts believe Blue Bird is more attractive than Ducommun.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
BLBD
Blue Bird
|
4 | 1 | 0 |
DCO
Ducommun
|
4 | 0 | 0 |
Blue Bird has a beta of 1.413, which suggesting that the stock is 41.302% more volatile than S&P 500. In comparison Ducommun has a beta of 1.360, suggesting its more volatile than the S&P 500 by 36.012%.
Blue Bird has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ducommun offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Blue Bird pays -- of its earnings as a dividend. Ducommun pays out -- of its earnings as a dividend.
Blue Bird quarterly revenues are $358.9M, which are larger than Ducommun quarterly revenues of $194.1M. Blue Bird's net income of $26M is higher than Ducommun's net income of $10.5M. Notably, Blue Bird's price-to-earnings ratio is 13.26x while Ducommun's PE ratio is 37.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blue Bird is 1.05x versus 1.65x for Ducommun. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
BLBD
Blue Bird
|
1.05x | 13.26x | $358.9M | $26M |
DCO
Ducommun
|
1.65x | 37.12x | $194.1M | $10.5M |
Flowserve has a net margin of 7.26% compared to Blue Bird's net margin of 6.46%. Blue Bird's return on equity of 69.97% beat Flowserve's return on equity of 13.71%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
BLBD
Blue Bird
|
19.75% | $0.79 | $283.1M |
FLS
Flowserve
|
32.27% | $0.56 | $3.6B |
Blue Bird has a consensus price target of $51.57, signalling upside risk potential of 20.44%. On the other hand Flowserve has an analysts' consensus of $64.30 which suggests that it could grow by 19.54%. Given that Blue Bird has higher upside potential than Flowserve, analysts believe Blue Bird is more attractive than Flowserve.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
BLBD
Blue Bird
|
4 | 1 | 0 |
FLS
Flowserve
|
8 | 2 | 0 |
Blue Bird has a beta of 1.413, which suggesting that the stock is 41.302% more volatile than S&P 500. In comparison Flowserve has a beta of 1.250, suggesting its more volatile than the S&P 500 by 24.968%.
Blue Bird has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Flowserve offers a yield of 1.56% to investors and pays a quarterly dividend of $0.21 per share. Blue Bird pays -- of its earnings as a dividend. Flowserve pays out 39.06% of its earnings as a dividend. Flowserve's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Blue Bird quarterly revenues are $358.9M, which are smaller than Flowserve quarterly revenues of $1.1B. Blue Bird's net income of $26M is lower than Flowserve's net income of $73.9M. Notably, Blue Bird's price-to-earnings ratio is 13.26x while Flowserve's PE ratio is 25.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blue Bird is 1.05x versus 1.54x for Flowserve. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
BLBD
Blue Bird
|
1.05x | 13.26x | $358.9M | $26M |
FLS
Flowserve
|
1.54x | 25.14x | $1.1B | $73.9M |
Oshkosh has a net margin of 7.26% compared to Blue Bird's net margin of 4.85%. Blue Bird's return on equity of 69.97% beat Oshkosh's return on equity of 15.17%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
BLBD
Blue Bird
|
19.75% | $0.79 | $283.1M |
OSK
Oshkosh
|
17.29% | $1.72 | $5.7B |
Blue Bird has a consensus price target of $51.57, signalling upside risk potential of 20.44%. On the other hand Oshkosh has an analysts' consensus of $126.62 which suggests that it could grow by 2.83%. Given that Blue Bird has higher upside potential than Oshkosh, analysts believe Blue Bird is more attractive than Oshkosh.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
BLBD
Blue Bird
|
4 | 1 | 0 |
OSK
Oshkosh
|
9 | 5 | 0 |
Blue Bird has a beta of 1.413, which suggesting that the stock is 41.302% more volatile than S&P 500. In comparison Oshkosh has a beta of 1.432, suggesting its more volatile than the S&P 500 by 43.228%.
Blue Bird has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oshkosh offers a yield of 1.58% to investors and pays a quarterly dividend of $0.51 per share. Blue Bird pays -- of its earnings as a dividend. Oshkosh pays out 17.61% of its earnings as a dividend. Oshkosh's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Blue Bird quarterly revenues are $358.9M, which are smaller than Oshkosh quarterly revenues of $2.3B. Blue Bird's net income of $26M is lower than Oshkosh's net income of $112.2M. Notably, Blue Bird's price-to-earnings ratio is 13.26x while Oshkosh's PE ratio is 13.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blue Bird is 1.05x versus 0.77x for Oshkosh. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
BLBD
Blue Bird
|
1.05x | 13.26x | $358.9M | $26M |
OSK
Oshkosh
|
0.77x | 13.16x | $2.3B | $112.2M |
PACCAR has a net margin of 7.26% compared to Blue Bird's net margin of 6.79%. Blue Bird's return on equity of 69.97% beat PACCAR's return on equity of 19.56%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
BLBD
Blue Bird
|
19.75% | $0.79 | $283.1M |
PCAR
PACCAR
|
17.72% | $0.96 | $33.7B |
Blue Bird has a consensus price target of $51.57, signalling upside risk potential of 20.44%. On the other hand PACCAR has an analysts' consensus of $102.45 which suggests that it could grow by 7.4%. Given that Blue Bird has higher upside potential than PACCAR, analysts believe Blue Bird is more attractive than PACCAR.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
BLBD
Blue Bird
|
4 | 1 | 0 |
PCAR
PACCAR
|
6 | 13 | 2 |
Blue Bird has a beta of 1.413, which suggesting that the stock is 41.302% more volatile than S&P 500. In comparison PACCAR has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.056%.
Blue Bird has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACCAR offers a yield of 1.32% to investors and pays a quarterly dividend of $0.33 per share. Blue Bird pays -- of its earnings as a dividend. PACCAR pays out 54.99% of its earnings as a dividend. PACCAR's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Blue Bird quarterly revenues are $358.9M, which are smaller than PACCAR quarterly revenues of $7.4B. Blue Bird's net income of $26M is lower than PACCAR's net income of $505.1M. Notably, Blue Bird's price-to-earnings ratio is 13.26x while PACCAR's PE ratio is 14.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blue Bird is 1.05x versus 1.55x for PACCAR. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
BLBD
Blue Bird
|
1.05x | 13.26x | $358.9M | $26M |
PCAR
PACCAR
|
1.55x | 14.45x | $7.4B | $505.1M |
Xos has a net margin of 7.26% compared to Blue Bird's net margin of -173.26%. Blue Bird's return on equity of 69.97% beat Xos's return on equity of -104.41%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
BLBD
Blue Bird
|
19.75% | $0.79 | $283.1M |
XOS
Xos
|
20.6% | -$1.26 | $45.9M |
Blue Bird has a consensus price target of $51.57, signalling upside risk potential of 20.44%. On the other hand Xos has an analysts' consensus of $6.00 which suggests that it could grow by 79.64%. Given that Xos has higher upside potential than Blue Bird, analysts believe Xos is more attractive than Blue Bird.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
BLBD
Blue Bird
|
4 | 1 | 0 |
XOS
Xos
|
1 | 1 | 0 |
Blue Bird has a beta of 1.413, which suggesting that the stock is 41.302% more volatile than S&P 500. In comparison Xos has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Blue Bird has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xos offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Blue Bird pays -- of its earnings as a dividend. Xos pays out -- of its earnings as a dividend.
Blue Bird quarterly revenues are $358.9M, which are larger than Xos quarterly revenues of $5.9M. Blue Bird's net income of $26M is higher than Xos's net income of -$10.2M. Notably, Blue Bird's price-to-earnings ratio is 13.26x while Xos's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blue Bird is 1.05x versus 0.55x for Xos. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
BLBD
Blue Bird
|
1.05x | 13.26x | $358.9M | $26M |
XOS
Xos
|
0.55x | -- | $5.9M | -$10.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.